Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Thromb Thrombolysis

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    July 2018
  1. JACKSON LR 2ND, Kim S, Shrader P, Blanco R, et al
    Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    J Thromb Thrombolysis. 2018 Jul 26. pii: 10.1007/s11239-018-1715.
    PubMed     Text format     Abstract available


  2. AGIRBASLI M
    Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2018 Jul 25. pii: 10.1007/s11239-018-1717.
    PubMed     Text format    


    June 2018
  3. CHI G, Yee MK, Kalayci A, Kerneis M, et al
    Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
    J Thromb Thrombolysis. 2018 Jun 26. pii: 10.1007/s11239-018-1703.
    PubMed     Text format     Abstract available


  4. KHEIRI B, Haykal T, Abdalla A, Osman M, et al
    Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis.
    J Thromb Thrombolysis. 2018 Jun 15. pii: 10.1007/s11239-018-1694.
    PubMed     Text format    


  5. HUGHEY AB, Gu X, Haymart B, Kline-Rogers E, et al
    Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)) registry to the RE-LY, ROCKET-AF, and ARISTOTLE
    J Thromb Thrombolysis. 2018 Jun 14. pii: 10.1007/s11239-018-1698.
    PubMed     Text format     Abstract available


  6. MONAGLE SR, Hirsh J, Bhagirath VC, Ginsberg JS, et al
    Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada.
    J Thromb Thrombolysis. 2018 Jun 5. pii: 10.1007/s11239-018-1692.
    PubMed     Text format     Abstract available


    May 2018
  7. ROSSI AP, Facchinetti R, Ferrari E, Nori N, et al
    Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2018 May 14. pii: 10.1007/s11239-018-1679.
    PubMed     Text format     Abstract available


    April 2018
  8. GRANT SJ, Kothari S, Gimotty PA, Gooneratne NS, et al
    Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
    J Thromb Thrombolysis. 2018 Apr 2. pii: 10.1007/s11239-018-1651.
    PubMed     Text format     Abstract available


    February 2018
  9. BRUNETTI ND, Tarantino N, De Gennaro L, Correale M, et al
    Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis.
    J Thromb Thrombolysis. 2018 Feb 5. pii: 10.1007/s11239-018-1622.
    PubMed     Text format     Abstract available


    December 2017
  10. RUSSO V, Rago A, Papa AA, D'Onofrio A, et al
    Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study.
    J Thromb Thrombolysis. 2017 Dec 19. pii: 10.1007/s11239-017-1599.
    PubMed     Text format     Abstract available


  11. SHIN H, Cho MC, Kim RB, Kim CH, et al
    Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2017 Dec 2. pii: 10.1007/s11239-017-1590.
    PubMed     Text format     Abstract available


    July 2017
  12. PIPILIS A, Makrygiannis S, Anagnostou G, Kaliampakos S, et al
    Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures.
    J Thromb Thrombolysis. 2017;44:9-13.
    PubMed     Text format     Abstract available


    June 2017
  13. HELMERT S, Marten S, Mizera H, Reitter A, et al
    Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry.
    J Thromb Thrombolysis. 2017 Jun 22. doi: 10.1007/s11239-017-1519.
    PubMed     Text format     Abstract available


    March 2017
  14. STEPPICH B, Dobler F, Brendel LC, Hessling G, et al
    Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2017 Mar 18. doi: 10.1007/s11239-017-1495.
    PubMed     Text format     Abstract available


    February 2017
  15. CAPPELLARI M, Bovi P
    Early use of direct oral anticoagulants after TIA/stroke in patients with atrial fibrillation: a 2016 update.
    J Thromb Thrombolysis. 2017 Feb 6. doi: 10.1007/s11239-017-1475.
    PubMed     Text format    


  16. MARSICO F, Cecere M, Parente A, Paolillo S, et al
    Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
    J Thromb Thrombolysis. 2017;43:139-148.
    PubMed     Text format     Abstract available


    November 2016
  17. ZIRLIK A, Bode C
    Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  18. BASARAN O, Dogan V, Beton O, Tekinalp M, et al
    Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  19. HALE ZD, Kong X, Haymart B, Gu X, et al
    Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  20. LAU YC, Xiong Q, Blann AD, Lip GY, et al
    Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  21. SO CH, Eckman MH
    Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  22. LAU YC, Xiong Q, Shantsila E, Lip GY, et al
    Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  23. KHAN F, Huang H, Datta YH
    Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  24. ROSWELL RO, Greet B, Shah S, Bernard S, et al
    Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.
    J Thromb Thrombolysis. 2016;42:179-85.
    PubMed     Text format     Abstract available


    July 2016
  25. RILINGER J, Meyer M, Schnabel K, Weik P, et al
    High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  26. CAPPELLARI M, Carletti M, Danese A, Bovi P, et al
    Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  27. MINHAS AS, Jiang Q, Gu X, Haymart B, et al
    Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  28. SAJI N, Kimura K, Tateishi Y, Fujimoto S, et al
    Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  29. YAVUZ B, Ayturk M, Ozkan S, Ozturk M, et al
    A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  30. LAU YC, Xiong Q, Ranjit P, Lip GY, et al
    Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    February 2015
  31. JACKSON LR 2ND, Peterson ED, Okeagu E, Thomas K, et al
    Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.
    J Thromb Thrombolysis. 2015;39:222-7.
    PubMed     Text format     Abstract available


  32. ROGNONI C, Marchetti M, Quaglini S, Liberato NL, et al
    Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
    J Thromb Thrombolysis. 2015;39:149-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: